BTIG Keeps a Hold Rating on Intuitive Surgical

By Carrie Williams

BTIG analyst Sean Lavin reiterated a Hold rating on Intuitive Surgical (NASDAQ: ISRG) on June 13. The company’s shares closed yesterday at $905.83, close to its 52-week high of $937.15.

According to, Lavin is a 5-star analyst with an average return of 11.0% and a 60.0% success rate. Lavin covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Trivascular Technologies, and Obalon Therapeutics Inc.

Currently, the analyst consensus on Intuitive Surgical is Moderate Buy and the average price target is $856.42, representing a -5.5% downside.

In a report issued on May 29, Canaccord Genuity also downgraded the stock to Hold with a $870 price target.

Based on Intuitive Surgical’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $672 million and quarterly net profit of $180 million. In comparison, last year the company earned revenue of $594 million and had a net profit of $136 million.

Based on the recent corporate insider activity of 79 insiders, corporate insider sentiment is negative on the stock. Last month, Curet Myriam, the SVP & CMO of ISRG sold 3,385 shares for a total of $2,833,956.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.